John C. Flickinger, MD, FACR, is a professor of radiation oncology and neurological surgery at the University of Pittsburgh School of Medicine. Dr. Flickinger holds an interest in spine tumors, brain tumors, metastatic diseases, effects of radiation on normal tissue, and the mathematical modeling of radiation response.
Dr. Flickinger is board-certified in therapeutic radiology. He received an undergraduate degree at the University of Pittsburgh, and received a medical degree at The University of Chicago Prtizker School of Medicine. Dr. Flickinger completed a residency in radiation oncology at Harvard Medical School at Massachusetts General Hospital in Boston.
Dr. Flickinger is a member of professional organizations including, American Society for Radiation Oncology, American College of Radiology, and the American Society of Clinical Oncology.
Dr. Andrea Bezjak is a Professor in the Departments of Radiation Oncology and Clinical Epidemiology & Health Care Research at the University of Toronto, Canada and staff Radiation oncologist at the Princess Margaret Cancer Center/University Health Network.
She holds the Addie MacNaughton Chair in Thoracic Radiation Oncology at the University of Toronto. She has authored or co-authored more than 190 peer-reviewed manuscripts and has been a principal investigator of multi-center clinical trials in lung cancer. Her research is in image-guided and stereotactic radiotherapy for lung cancer, palliative radiation, quality of life and symptom assessment. She has been a member of IASLC since 1995 and is one of the co-Presidents of the upcoming 2018 World Conference on Lung Cancer in Toronto.
Dr. Sten Myrehaug MD, FRCPC
- 2010-2011: Clinical Research Fellow, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
- 2005-2010: Postgraduate Training, Department of Radiation Oncology, University of Toronto, Canada
- 2001-2005: Doctor of Medicine with Special Training in Research, University of Alberta, Canada
- 1997-2001: Bachelor of Science, University of Alberta, Canada
Appointments and affiliations:
- Radiation oncologist and clinician investigator, Odette Cancer Centre, Sunnybrook Health Sciences Centre
- Assistant professor, Department of Radiation Oncology, University of Toronto
- Central nervous system malignancies
- Gastrointestinal malignancies
- Neuroendocrine malignancies
Medical Oncology Registrar
a the Beacon Hospital
Ana is a Medical Oncology Registrar at the Beacon Hospital
Beacon Hospital is a private hospital accredited by the Joint Commission International (JCI).
Located in South Dublin, Beacon Hospital is one of the most advanced private hospitals in Europe, with over 1000 Consultants, nurses and healthcare professionals. Beacon Hospital provides 24 hour, world-class acute care services including orthopaedics, physiotherapy, cardiology, women’s health, urology, cardiothoracic surgery, vascular surgery, plastic & reconstructive surgery, ENT, neurology, general surgery, comprehensive cancer care, paediatrics, emergency medicin
Mohamed Galal Ibrahim
Head of Physics Department
Hermitage Medical Clinic
Cyberknife (Acceptance, commissioning, planning)
LINAC commissioning and QA
Panning and plan checking
Physics quality manual maintaining
Dr. Ian Brennan
Dr Ian Brennan has recently joined our Radiology team. Ian graduated with honours from UCD Medical School in 2000.
Following four years of basic surgical training and research in Dublin and Cork he commenced his Radiology specialty training in St James’s Hospital in 2006. In 2012, following completion of two years of specialist Fellowship training in Boston, he was appointed staff interventional and diagnostic radiologist at Beth Israel Deaconess Medical Center with a faculty appointment to Harvard Medical School.
In 2015 he returned home to Ireland to take up a consultant appointment at St James’s Hospital Dublin, specialising in interventional radiology, interventional oncology and abdominal diagnostic imaging. His practice at the Beacon hospital will encompass all aspects of radiology and in particular oncologic imaging and minimally invasive therapy.
Chief Medical Physicist Beacon Hospital
Mr Luke Rock is the Chief Medical Physicist and Radiation Protection Advisor for Beacon Hospital. Having completed a residency programme at St. Luke’s Hospital, Dublin, Mr Rock took a medical physicist position at the Hospital of the University of Pennsylvania in Philadelphia. Upon returning to Ireland, Mr Rock worked at University College Hospital Galway, where he commissioned Ireland’s first IMRT programme, then moved to Beacon Hospital where he oversaw the implementation of Ireland’s first SABR programme and the first Vision RT SRS programme in Europe.
Mr Rock has presented research at several national and international conferences and has published in peer reviewed journals. He is a member of several national and international organisations including the Irish and American Associations for Physicists in Medicine, Irish College of Physics in Medicine and the Institute for Physics and Engineering in Medicine (UK). Mr Rock was certified as a Therapeutic Radiological Physicist by the American Board of Radiology in 2006, accepted onto the register of Radiation Protection Advisors in Ireland in 2009 and registered as a Chartered Scientist by the Science Council in the UK in 2015.
Dr. Alina Mihai
Consultant Radiation Oncologist
Dr. Alina Mihai is full time Consultant Radiation Oncologist at Beacon Hospital, with expertise in high technology such as IMRT and stereotactic radiosurgery and stereotactic body radiotherapy. Dr. Mihai earned her Medical Degree and Specialty in Romania. Her training included clinical and research Fellowships in France (University of Rouen –Prof B.Dubray), and Canada. Between 2002-2005 at University of Toronto, where she was involved in development of forward planning IMRT for breast cancer and in assessing the role of central pathology review in DCIS breast. Between 2006-2007 Dr Mihai joined the staff of the Radiotherapy Department of the Cross Cancer Institute Edmonton (Alberta), initially as a Clinical Research fellow, subsequently as a full time locum Consultant. During this period she was involved in developing the tomotherapy technique for breast cancer treatments, as well as in implementing the PET-CT and myocardial perfusion scans in the process of radiotherapy planning for lung and breast malignancies.
Dr Mihai joined UPMC Beacon Hospital in July 2007. She has had a pivotal role in implementation and development of gated and image guided radiotherapy and stereotactic body radiotherapy at Beacon Hospital . Her expertise is in assessment of moving targets, SBRT for oligometastatic disease and IMRT for brain, prostate and lung cancers. In addition, she is actively involved in the development of UPMC pathways for therapeutic management of rectal, oesophageal and prostate cancers. She organised and leads the extracranial SBRT task group at Beacon Hospital. Dr Mihai earned her Master degree in Radiation Science (University of Toronto) in 2006.
Her present areas of research and publications include:
- SBRT for oligometastatic disease
- SBRT in elderly
- role of metabolic imaging in treatment planning and response assessment
She is member of several professional organizations including ICORG, ESTRO, ASTRO, EANO. She is site principal investigator in two clinical trials opened at Beacon Hospital and co-investigator in other two.
Professor John Armstrong is a Board Member and ex-chairman of the Irish Cancer Society. Professor Armstrong was trained at Memorial Sloan-Kettering Cancer Center, where he performed his residency and was Chief resident, attending for five years. He directed the lung cancer radiation research programme at Memorial Sloan-Kettering Cancer Center, and co-authored the chapter on non-small cell lung cancer chapter in 4th edition of DeVita, Hellman, and Rosenberg, Cancer: Principles and Practice of Oncology, Lippincott.
He is currently the Director of Research at St. Luke’s Hospital, Dublin. Professor Armstrong is the Principal Investigator for several clinical trials in the Irish Clinical Oncology Research Group.
Professor Armstrong has published numerous articles and has lectured extensively in the field of radiation oncology. He has been instrumental in the rollout of new procedures involving high-tech radiation therapy procedures such as Intensity Modulated Radiation Therapy, and stereotactic radiosurgery
Senior Medical Physicist
St Lukes Hospital
Currently works at the Department of Radiation Oncology, Saint Luke’s Hospital (Ireland). Christina does research in Clinical Trials, Oncology and Medical Technology.
Professor Dirk Verellen
PhD,Head of Medical Physics Radiation Oncology, Professor Biomedical Physics
Qualifications / education:
PhD Medical Sciences, Vrije Universiteit Brussel (VUB), 1998
Qualified Medical Physicist, Radiation Oncology, 1991
MSc Physics, Antwerp University, 1989
Aggregated for higher secondary education, 1989
Main areas of professional interest/specialisation:
The practical issues concerning implementation of high precision conformal radiotherapy
and image-guidance in a clinical environment.
Establishing a safety culture in radiation oncology.
Head of Medical Physics Radiation Oncology, Iridium Cancer Network, from 2016.
Head of Medical Physics, Radiation Oncology, UZ Brussel, from 1996-2016
Professor Biomedical Physics, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, from 2003.
Qualified Medical Physicist, Radiation Oncology, UZ Brussel, 1991-1995
Mohsen Javadpour currently works at the National Centre for Neurosurgery, Beaumont Hospital. Mohsen does research in Neurosurgery. Their most recent publication is ‘IgG4 hypophysitis – a rare and underdiagnosed cause of pituitary gland and stalk mass-like thickening.’
clinical lead st luke’s ratiation oncology network beaumont hospital
Dr. Clare Faul
Clinical lead St Luke’s Radiation Oncology Network- Beaumont Hospital
Clinical Fellow Radiation Oncology
1/1/93-31/3/94 Toronto Sunnybrook
Regional Cancer Center,
University of Toronto, Ontario, Canada
Assistant Professor Radiation Oncology
1996-2000 University of Pittsburgh,
University of Pittsburgh Medical Center,
Magee Women’s Hospital.
The Department of Radiation Oncology, University of Pittsburgh, is an integral member of the Pittsburgh Cancer Institute, a Comprehensive Cancer Centre as designated by the National Cancer Institute.
Specialization in breast and gynecologic oncology.
Programme Director High Dose Rate Brachytherapy: University of Pittsburgh.
Certified in HDR brachytherapy and Nuclear Medicine (radiopharmaceutical therapy).
Consultant Radiation Oncologist
May 2002 – present St Luke’s radiation Oncology Network
Consultant Radiaiton Oncologist |Hermitage Clinic.
1998 -2000 Program Director High Dose Rate Brachytherapy, University of Pittsburgh.
2004 – 2010 Appointed Chief Examiner Final Fellowship Radiation Oncology, Faculty of Radiology, RCSI
2002-presnt Lecturer RCSI
2010 Vice Dean Faculty of Radiologists, RCSI.
2011-present Clinical Lead and chair of senior management group SLRON @ Beaumont Hospital
Ann Marie Kennedy
Principal Medical Physicist at Beacon Hospital
Currently works at the Department of Radiotherapy, UPMC Beacon Hospital, Dublin. Anne marie does research in Medical Physics.
Anne Marie is a Principal Medical Physicist at Beacon Hospital. Anne Marie completed a research Masters in Medical Imaging in NUI Galway followed by a medical physicist training program in St. Luke’s Hospital, Rathgar. Anne Marie has since worked in Belvoir Park Hospital, Mater Private Hospital and she joined Beacon Hospital in 2008.
Anne Marie was the lead physicist in the Implementation of Deep Inspiration Breath Hold technique for Left Breast Cancer patients at Beacon Hospital. She has presented at national and international conferences. Anne Marie is actively involved in all SABR and SRS programs at Beacon. She is a member of IAPM and Irish College of Physics in Medicine.
Dr. Pierre Thirion
Specialist Consultant ,St Lukes
Dr Pierre Thirion, is a French trained radiation oncologist, presently holding a permanent specialist consultant position in St Luke’s Hospital, Dublin, and chairperson of the Radiation Oncology department. Dr Thirion completed his basic medical training at the University Paris V-René Descartes Medical School.
He completed his Fellowship in Radiation Oncology (University Paris-V), rotating through the main Parisian radiotherapy departments. In 1998, he completed an additional diploma in medical oncology (University Paris-XI). After working for two years as a Chef de Clinique des Universités – Assistant des Hôpitaux de Paris (Henri Mondor Hospital, Créteil, France), he moved to Ireland in 1999 and took a position of Clinical/Research Senior Registrar in St Luke’s Hospital, Dublin.
Since 2002, he has been working as a Consultant Radiation Oncologist at the latter hospital. Dr Thirion has a special interest in the treatment of prostate and other genito-urinary cancer, lung tumour, breast cancer, gastro-intestinal malignancies and lymphoma. He has a recognised expertise in new radiotherapy technologies, including IMRT and brachytherapy, and had a major role in the implementation and development of extra-cranial stereotactic radiation therapy in Beacon Hospital.
Dr Thirion completed a MD in radiobiology at the Curie Research Institute, Paris (University Paris XI-Paris Sud, 1996) and a post-graduate diploma in statistics (Trinity College Dublin, 2002).
His present areas of research and publications include:
- clinical trials methodology and meta-analyses
- the development of new radiotherapy technologies
- the implementation radiotherapy-oriented clinical trials.
He is the principal investigator of several national and international clinical trials, and is an executive member of the All Ireland Cooperative Oncology Research Group (ICORG) and other international research group (EORTC).
Dr Elbeltagi graduated from Medical School in 1994. He received his Masters degree in 1999 and PhD/MD in 2004 (Cairo). He received his FRCR in 2006 in the UK. During this period, he trained and received fellowships in various advanced radiotherapy techniques: Stereotactic Radiotherapy in The Royal Marsden Hospital UK, Prostate Brachytherapy in Mount Vernon Hospital UK and IMRT in Princess Margaret Hospital Canada.
He was appointed as a Consultant Radiation Oncologist in May 2013 and works at St James’s and St. Luke’s Hospitals. He sub-specialises in the radiotherapy treatment of breast and genitourinary cancers.
Dr Elbeltagi is an active member of many international radiation oncology societies. He has presented research at international conferences, he has numerous publications and is the first author in many peer reviewed Journals e.g., The Green Journal and the Clinical Oncology Journal.
Dr. Paul Joseph Kelly – enrolled in Specialist Registration run by Irish Medical Council with reference number 124235. He is one of one thousand and six hundred and fourty three medical practitioners registered in the region of Cork county. Dr. Paul Joseph Kelly gained his qualifications of Bachelor of Medicine and Bachelor of Surgery in University College Cork with five hundred and eighty sixth doctors graduated in 2002. Doctor Kelly also completed training programme for specialists of Radiation Oncologist three years ago.
Dr Ray McDermott
Consultant Medical Oncologist of Beacon Medical Clinic
Dr Ray McDermott commenced his training in Medical Oncology at the Mater Hospital, Dublin during which time he completed an MBA in Health Services Management. He went on to The Institut Curie, Paris (2000-2002) where he completed a PhD in Tumour Immunology. He subsequently completed his clinical training at Fox Chase Cancer Center, Philadelphia (2002-2004), where he furthered an interest in Genito-Urinary Oncology. During this training period, he published over twenty peer reviewed articles and Book Chapters. He took up a post as Consultant Medical Oncologist at the Adelaide Meath & National Childrens Hospital, Tallaght in July 2004.
In 2006, Dr McDermott was instrumental in establishing Ireland as a main member of the Eastern Co-Operative Group, the largest clinical trials group in the USA with over 70 active studies. Dr McDermott is the Principal Investigator for Ireland in this initiative and is involved in twice yearly meetings with ECOG to develop this relationship. Dr McDermott is currently Vice-Chair of ICORG, the Irish Clinical Oncology Research Group. Under the auspices of the National Cancer Control Programme and the establishment of ‘Centres of Excellence’, Dr McDermott’s public hospital commitment has recently been split between AMNCH and St Vincent’s University Hospital, where he pursues his interest in genito-urinary and pancreas cancers. Along with Dr Jennifer Westrup, he has been involved in the establishment and growth of the cancer services at Beacon
We are delighted to announce
The Annual Irish Radiosurgery and Stereotactic Ablative Radiotherapy Symposium
will take place on 28th – 29th May 2018, at Convention Centre Dublin,
Starting 2018, this event is jointly organized by Beacon Hospital, St Luke’s Institute of Cancer Research and Hermitage Medical Clinic. This symposium aims to increase the awareness and knowledge of the indications and techniques of intra-cranial SRS and extra-cranial SBRT, at a time when an expansion of SRS/SBRT activity is planned across Ireland and the European Continent. This two day, fully interactive educational program will cover some of the fundamentals and advanced concepts of SRS/SBRT, technological challenges, quality assurance and patient safety, and the present and future clinical applications. Interactive workshops on treatment planning, respiratory motion analysis and multimodality imaging for intra-cranial planning will be run during the symposium.
The symposium faculty has significant links with the academic and research world, both nationally and internationally, as well as Trans-European experience. The target audience includes Radiation Oncologists, Medical Physicists, Radiation Therapists, and allied health professionals, as well as Neurosurgeons, Medical Oncologists and Researchers.
Applications were made for ESTRO endorsement and EACCME accreditation
Places are limited.
Alina Mihai MD MSc
on behalf of the Scientific and Organizing Committee
of the Irish Annual SRS/SABR Symposium
Agenda Day 1 - 28th
Agenda Day 2 - 29th
Call for Abstracts. Exhibit your Poster
The Future of Health Care – Collaboration is key to Excellence in Healthcare
Annual Irish Stereotactic Radiosurgery and Stereotactic Ablative Radiotherapy Symposium
Call for Abstracts The Scientific Committee of the 6th International SRS/SBRT symposium are pleased to announce the 2018 SRS/SBRT Young Investigator’s Awards. We are now calling for abstracts The Young Investigator’s Award is open to young professionals (physicians, residents, physicists, and therapists) working in the field of radiotherapy/stereotactic radiosurgery. Six finalists will be selected from the abstracts for poster discussion at the 2018 Young Investigator Awards held during the 6th International SRS/SBRT Symposium. The presentations will be judged and awards presented at the end of the meeting. Interested candidates should submit via the form below, we will be in-touch shortly
Benefits of Submitting to this International Event
1) All applicants receive a promotional code discount for the Future Health Summit.
2) All Abstracts accepted receive a full rebate for booked registrations for the event
3) Get Published in our Abstract Booklet and on our content hub.
4) Display your research to over 2000 attendees at the event
The winners of each category receive a trophy and the Overall winner will receive a monetary prize
The closing date is the Friday the 20th April 2018 and the review process will conclude by Monday 30th April 2018 and presenters should expect to receive feedback on their abstract submission no later than Monday 7th of May 2018.The Judging Review Committee will evaluate submissions for quality, relevance to the conference, theme, clarity, originality and timeliness.
Submit your Abstract Now by completing the form Below
The following information should be included on the abstract:
The title of the abstract and full name of the presenting author and all co- authors separated by commas. Submissions should clearly state the objectives/aims, method, results & conclusions of the study. The abstract should not contain bibliographic references, tables or appendices. The abstract should be approximately 250 words but no more than 500 (count not including title/authors). By submitting your abstract, you are confirming that all authors have approved the submission, and agree to your abstract appearing on our website. All sources of financial sponsorship or support of the study should be stated clearly at the end of the abstract.
For any queries please contact us via mail on firstname.lastname@example.org or call 00353(01)7008508